Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy

OncoImmunology

Volumn 5, Issue 2, 2016, Pages

  Ladoire, Sylvain ^a,b   Enot, David ^c   Andre, Fabrice ^c   Zitvogel, Laurence ^b,d,e   Kroemer, Guido ^b,c,f,g,h  

^a Biostatistic and Quality of Life Unit Georges François Leclerc Center   (France)

^b INSERM   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e Center of Clinical Investigations in Biotherapies of Cancer   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Breast cancer; Histology; HMGB1; Immunogenic cell death; LC3B; P62; SQSTM1

Indexed keywords

EID: 84959449499     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1082706     Document Type: Article

References (10)

1. L.Zitvogel, L.Galluzzi, M.J.Smyth, G.Kroemer. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 2013; 39:74-88; PMID:23890065; http://dx.doi.org/10.1016/j.immuni.2013.06.014
2. G.Kroemer, L.Galluzzi, L.Zitvogel. Immunological effects of chemotherapy in spontaneous breast cancers. Oncoimmunology 2013; 2:e27158; PMID:24498568; http://dx.doi.org/10.4161/onci.27158
3. G.Stoll, D.Enot, B.Mlecnik, J.Galon, L.Zitvogel, G.Kroemer. Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy. Oncoimmunology 2014; 3:e27884; PMID:24790795; http://dx.doi.org/10.4161/onci.27884
4. L.Senovilla, I.Vitale, I.Martins, M.Tailler, C.Pailleret, M.Michaud, L.Galluzzi, S.Adjemian, O.Kepp, M.Niso-Santano An immunosurveillance mechanism controls cancer cell ploidy. Science 2012; 337:1678-84; PMID:23019653; http://dx.doi.org/10.1126/science.1224922
5. E.Vacchelli, L.Senovilla, A.Eggermont, W.H.Fridman, J.Galon, L.Zitvogel, G.Kroemer, L.Galluzzi. Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2013; 2:e23510; PMID:23687621; http://dx.doi.org/10.4161/onci.23510
6. A.Q.Sukkurwala, S.Adjemian, L.Senovilla, M.Michaud, S.Spaggiari, E.Vacchelli, E.E.Baracco, L.Galluzzi, L.Zitvogel, O.Kepp, G.Kroemer. Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. Oncoimmunology 2014; 3:e28473; PMID:25050214; http://dx.doi.org/10.4161/onci.28473
7. O.Kepp, L.Senovilla, I.Vitale, E.Vacchelli, S.Adjemian, P.Agostinis, L.Apetoh, F.Aranda, V.Barnaba, N.Bloy Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology 2014; 3:e955691; PMID:25941621; http://dx.doi.org/10.4161/21624011.2014.955691
8. S.Rao, L.Tortola, T.Perlot, G.Wirnsberger, M.Novatchkova, R.Nitsch, P.Sykacek, L.Frank, D.Schramek, V.Komnenovic A dual role for autophagy in a murine model of lung cancer. Nat Commun 2014; 5:3056; PMID:24445999; http://dx.doi.org/10.1038/ncomms4056
9. M.Michaud, X.Xie, J.M.Bravo-San Pedro, L.Zitvogel, E.White, G.Kroemer. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology 2014; 3:e944047; PMID:25610726; http://dx.doi.org/10.4161/21624011.2014.944047
10. S.Ladoire, F.Penault-Llorca, L.Senovilla, C.Dalban, D.Enot, C.Locher, N.Prada, V.Poirier-Colame, K.Chaba, L.Arnould Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer. Autophagy 2015 Oct 3; 11(10):1878-90; PMID:26506894; http://dx.doi.org/10.1080/15548627.2015.1082022